FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

11753911000001100: Orencia 250mg powder for concentrate for solution for infusion vials (Bristol-Myers Squibb Pharmaceuticals Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2007. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
42799001000001110 Orencia 250mg powder for concentrate for solution for infusion vials (Bristol-Myers Squibb Pharmaceuticals Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
42799101000001111 Orencia 250mg powder for concentrate for solution for infusion vials (Bristol-Myers Squibb Pharmaceuticals Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Orencia 250mg powder for concentrate for solution for infusion vials (Bristol-Myers Squibb Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Orencia 250mg powder for concentrate for solution for infusion vials (Bristol-Myers Squibb Pharmaceuticals Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction hospital only true Inferred relationship Existential restriction modifier
Orencia 250mg powder for concentrate for solution for infusion vials (Bristol-Myers Squibb Pharmaceuticals Ltd) Is a Abatacept 250mg powder for solution for injection vials true Inferred relationship Existential restriction modifier
Orencia 250mg powder for concentrate for solution for infusion vials (Bristol-Myers Squibb Pharmaceuticals Ltd) Has active ingredient Abatacept true Inferred relationship Existential restriction modifier
Orencia 250mg powder for concentrate for solution for infusion vials (Bristol-Myers Squibb Pharmaceuticals Ltd) Has manufactured dose form Powder for conventional release solution for injection false Inferred relationship Existential restriction modifier
Orencia 250mg powder for concentrate for solution for infusion vials (Bristol-Myers Squibb Pharmaceuticals Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Orencia 250mg powder for concentrate for solution for infusion vials (Bristol-Myers Squibb Pharmaceuticals Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Orencia 250mg powder for concentrate for solution for infusion vials (Bristol-Myers Squibb Pharmaceuticals Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Orencia 250mg powder for concentrate for solution for infusion vials (Bristol-Myers Squibb Pharmaceuticals Ltd) Is a Orencia true Inferred relationship Existential restriction modifier
Orencia 250mg powder for concentrate for solution for infusion vials (Bristol-Myers Squibb Pharmaceuticals Ltd) Has specific active ingredient Abatacept true Inferred relationship Existential restriction modifier
Orencia 250mg powder for concentrate for solution for infusion vials (Bristol-Myers Squibb Pharmaceuticals Ltd) Has dispensed dose form Powder for infusion solution false Inferred relationship Existential restriction modifier
Orencia 250mg powder for concentrate for solution for infusion vials (Bristol-Myers Squibb Pharmaceuticals Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Orencia 250mg powder for concentrate for solution for infusion vials (Bristol-Myers Squibb Pharmaceuticals Ltd) Has manufactured dose form Powder for infusion solution false Inferred relationship Existential restriction modifier
Orencia 250mg powder for concentrate for solution for infusion vials (Bristol-Myers Squibb Pharmaceuticals Ltd) Has dispensed dose form Powder for conventional release solution for infusion true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Orencia 250mg powder for concentrate for solution for infusion vials (Bristol-Myers Squibb Pharmaceuticals Ltd) 1 vial Is pack of False Orencia 250mg powder for concentrate for solution for infusion vials (Bristol-Myers Squibb Pharmaceuticals Ltd) Inferred relationship Existential restriction modifier
Orencia 250mg powder for concentrate for solution for infusion vials (Bristol-Myers Squibb Pharmaceuticals Ltd) 1 vial Has AMP True Orencia 250mg powder for concentrate for solution for infusion vials (Bristol-Myers Squibb Pharmaceuticals Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start